North America Corneal Transplant Market – Industry Trends and Forecast to 2031

Solicitud de índiceSolicitud de índice Hable con el analistaHable con el analista Comprar ahoraComprar ahora Consultar antes de comprarConsultar antes Informe de muestra gratuitoInforme de muestra gratuito

North America Corneal Transplant Market – Industry Trends and Forecast to 2031

  • Pharmaceutical
  • Published Report
  • Sep 2024
  • North America
  • 350 Páginas
  • Número de tablas: 102
  • Número de figuras: 54

North America Corneal Transplant Market

Tamaño del mercado en miles de millones de dólares

Tasa de crecimiento anual compuesta (CAGR) :  % Diagram

Diagram Período de pronóstico
2024 –2031
Diagram Tamaño del mercado (año base)
USD 207.02 Million
Diagram Tamaño del mercado (año de pronóstico)
USD 335.35 Million
Diagram Tasa de crecimiento anual compuesta (CAGR)
%
Diagram Jugadoras de los principales mercados
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

North America Corneal Transplant Market, By Procedure Type (Endothelial Keratoplasty, Penetrating Keratoplasty, Anterior Lamellar Keratoplasty (ALK), Corneal Limbal Stem Cell Transplant, Artifical Cornea Transplant, and Others), Type (Human Cornea and Synthetic), Donor Type (Autograft and Allograft), Graft Type (Partial Thickness Grafts (Lamellar) and Full Thickness Grafts (Penetrating)), Surgery Type (Conventional Surgery, Laser-Assisted Surgery), Indication (Fuch's Endothelial Dystrophy, Infectious Keratitis, Bullous Keratopathy, Keratoconus, Regraft Procedures, Corneal Scarring, Corneal Ulcers, and Others), Gender (Female and Male), Age Group (Geriatric, Adult, and Pediatric), End User (Hospitals, Eye Clinics, Ambulatory Surgical Centers, Academic & Research Institutes, and Others) - Industry Trends and Forecast to 2031

North America Corneal Transplant Market

North America Corneal Transplant Market Analysis and Size

The North America corneal implants market is driven by several factors, including the increasing prevalence of corneal diseases, a growing aging population, advances in technology, increasing demand for minimally invasive procedures, rising awareness of corneal transplantation, government initiatives and funding, increasing adoption of hybrid and toric lenses, growing popularity of cross-linking procedures, expanding indications for corneal implants, and a competitive landscape that fosters innovation. These factors are collectively driving the demand for corneal implants, particularly in developed countries, as patients seek effective treatments for vision disorders and conditions such as keratoconus, Fuchs' dystrophy, and pseudophakic bullous keratopathy.

Data Bridge Market Research analyzes that the North America corneal transplant market is expected to reach USD 335.35 million by 2031 from USD 207.02 million in 2023, is growing with a CAGR of 6.2% in the forecast period of 2024 to 2031.

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable 2016-2021)

Quantitative Units

Revenue in USD Million

Segments Covered

Procedure Type (Endothelial Keratoplasty, Penetrating Keratoplasty, Anterior Lamellar Keratoplasty (ALK), Corneal Limbal Stem Cell Transplant, Artifical Cornea Transplant, and Others), Type (Human Cornea and Synthetic), Donor Type (Autograft and Allograft), Graft Type (Partial Thickness Grafts (Lamellar) and Full Thickness Grafts (Penetrating)), Surgery Type (Conventional Surgery, Laser-Assisted Surgery), Indication (Fuch's Endothelial Dystrophy, Infectious Keratitis, Bullous Keratopathy, Keratoconus, Regraft Procedures, Corneal Scarring, Corneal Ulcers, and Others), Gender (Female and Male), Age Group (Geriatric, Adult, and Pediatric), End User (Hospitals, Eye Clinics, Ambulatory Surgical Centers, Academic & Research Institutes, and Others)

Countries Covered

U.S., Canada, Mexico

Market Players Covered

ZEISS Group (Carl Zeiss Meditec AG.), Alcon, CorneaGen, Ziemer Ophthalmic Systems AG, RUMEX International Co., among others.

Market Definition

The corneal transplant market refers to the medical field focused on surgical procedures that replace damaged or diseased corneas with healthy donor tissue. Corneal transplants, also known as keratoplasty, are performed to restore vision in patients suffering from conditions such as keratoconus, corneal scarring, infections, or corneal endothelial dysfunction. The market encompasses various types of transplant procedures, including penetrating keratoplasty (full-thickness corneal transplant) and endothelial keratoplasty (partial-thickness transplant), and is supported by advancements in surgical techniques, availability of donor tissues, and improved postoperative care. As eye disorders become more prevalent globally, and with technological innovations enhancing the success rate of surgeries, the corneal transplant market continues to grow, addressing the rising demand for vision restoration.

North America Corneal Transplant Market Dynamics:

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail as below:

Drivers

  • Increasing Prevalence of Eye Diseases

The increasing prevalence of eye diseases is a significant driver in the North America corneal transplant market, as conditions like keratoconus, Fuchs' endothelial dystrophy, and corneal scarring due to infections or trauma are becoming more common. These diseases can lead to severe vision impairment or blindness, prompting a growing demand for corneal transplants as a restorative treatment. The rise in eye disorders is often linked to factors such as aging populations, higher rates of diabetes, and increased exposure to environmental pollutants and UV radiation, which can damage the cornea. Also, advancements in diagnostic techniques are leading to earlier detection of these diseases, allowing for timely interventions, including corneal transplantation. Furthermore, greater awareness of corneal health and the availability of improved surgical techniques, such as Descemet's Membrane Endothelial Keratoplasty (DMEK) and Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK), are contributing to the growing acceptance of corneal transplants. As the burden of eye diseases continues to grow worldwide, the need for effective solutions like corneal transplants is expected to rise, fueling market growth.

For instance,

  • In June 2023, according to the article published in NCBI, a study was conducted to investigate the prevalence of keratoconus in a large German cohort and to evaluate possible associated factors. Keratoconus appears to be a rare corneal disease with a prevalence previously estimated at 1:2000. However, in recent relatively small studies, a higher prevalence was found. Prevalence is reported from 1: 6000 for US citizens, 1:1000 for Israeli adolescents, up to 1:20 for Saudi-Arabian Children. Newer studies detected prevalence estimates of 1:191 in New Zealand high school students. A prevalence of up to 1:84 was detected for young Australian adults. The prevalence of keratoconus treatment in the German population is approximately tenfold higher than previously reported in the literature using the latest technologies, namely Scheimpflug imaging, which act as a driver in the growth of the market.

Rising Geriatric Population

The rising geriatric population is a key driver in the North America corneal transplant market, as older adults are more susceptible to various eye conditions that can lead to corneal damage and the need for transplants. Age-related eye diseases, such as Fuchs' endothelial dystrophy, bullous keratopathy, and other degenerative corneal disorders, become more prevalent with advancing age, significantly increasing the demand for corneal transplants. Also, older adults are more likely to experience complications from cataract surgery or develop chronic conditions like diabetes, which can further contribute to corneal deterioration. As the North America population ages, the number of individuals requiring corneal transplants is expected to rise, particularly in regions with rapidly aging demographics. This trend is further fueled by increased awareness about the availability and success rates of corneal transplants, as well as advancements in surgical techniques that offer better outcomes and faster recovery times for older patients. As a result, the growing geriatric population is a major factor driving the expansion of the North America corneal transplant market, highlighting the need for accessible and effective treatment options for age-related corneal diseases.

Opportunity

  • Rise in Healthcare Infrastructure

The rise in healthcare infrastructure offers significant opportunities for the North America corneal transplant market by expanding access to transplant services. Enhanced infrastructure leads to the establishment of more hospitals and specialized clinics, making corneal transplants more accessible to a broader population. Improved facilities in underserved or rural areas ensure that patients who previously had limited access to specialized eye care can now receive essential transplant services.

Modernized healthcare facilities are equipped with advanced surgical technologies and diagnostic tools, which directly improve the success rates of corneal transplants and minimize complications. Specialized centers within these advanced systems provide focused expertise and resources, further enhancing surgical outcomes and patient care. The increased capacity of these facilities also supports a higher volume of transplant procedures, effectively addressing patient demand and reducing waiting times.

 For instance,

  • In April 2024, according to the article ‘The Rise of Hospital Infrastructure & Modernization Updates,’ the U.S. boasts of a robust healthcare infrastructure consisting of over 6,000 hospitals and thousands of small clinics, offering more than a million hospital beds to patients. This infrastructure encompasses a variety of essential elements, such as advanced research labs, cutting-edge technology, and a wide range of medical equipment. Moreover, the federal government has been providing funds for the continuous modernization of the country’s healthcare infrastructure
  • In August 2023, according to JLL India, India has been welcoming more investments and innovation to deal with future life-threatening diseases and pandemics that, in turn, help in growing the country’s healthcare and life sciences sector

Restraint/Challenge

  • The High Cost of Corneal Transplant Surgery

The high cost of corneal transplant surgery acts as a significant restraint on the growth of the North America corneal transplant market by limiting patient access and affordability, particularly in low- and middle-income countries. Corneal transplant procedures, including traditional Penetrating Keratoplasty (PK) and advanced techniques like Descemet’s Membrane Endothelial Keratoplasty (DMEK) or Descemet’s Stripping Automated Endothelial Keratoplasty (DSAEK), often involve substantial expenses not only for the surgical procedure itself but also for the associated costs of preoperative assessments, postoperative care, medications, and follow-up visits. Also, the cost of obtaining donor corneas, whether through eye banks or commercial sources, further contributes to the financial burden. In many regions, particularly those with limited healthcare infrastructure, these costs are exacerbated by a lack of insurance coverage or inadequate reimbursement policies, making corneal transplants financially inaccessible to a large portion of the population. Furthermore, the need for specialized surgical expertise and advanced equipment increases the overall expense, thereby restricting the availability of these procedures to well-equipped medical centers in urban areas. Consequently, the high costs associated with corneal transplant surgery hinder market growth by reducing the potential patient pool, especially in underserved regions where the burden of corneal diseases is often most significant and access to affordable healthcare is limited.

Recent Developments

  • In January 2024, Carl Zeiss India's Medical Technology Division showcased Cataract and Refractive Workflow at Phaco Festival by Nethradhama Super Speciality, Bengaluru. At the Phaco Festival, the spotlight shined on ZEISS's transformative impact on the Cataract and Corneal Refractive Workflows.
  • In June 2024, CorneaGen today announces the commercial launch of Corneal Tissue Addition for Keratoplasty (CTAK), an innovative and extremely effective solution to corneal contouring for keratoconic eyes. Developed by CorneaGen in partnership with CTAK LLC and Ziemer, CTAK provides patient ready, gamma-irradiated sterile, non-immunogenic corneal tissue segments, laser cut and customized to patients’ specific cone severity and location
  • In January 2024, Seattle-based CorneaGen is excited to announce an expansion of their eye recovery services throughout northern and southern California. Through this expansion of service, CorneaGen will now provide both eye recovery and processing services of donor tissue for facilities throughout the state, resulting in an even better experience for the patients, families, and staff of their California partner facilities.
  • In August 2024, ZEISS extends its global refractive industry momentum with more than 10 million eyes treated with ZEISS SMILE and ZEISS SMILE pro; ZEISS announces first treatment in the CE market for hyperopia with lenticule extraction using ZEISS SMILE pro technology

North America Corneal Transplant Market Scope

The North America corneal transplant market is segmented into eight notable segments based on procedure type, type, donor type, graft type, surgery type, indication, gender, age group, and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.

Procedure Type

  • Endothelial Keratoplasty
  •  Penetrating Keratoplasty
  •  Anterior Lamellar Keratoplasty (ALK)
  •  Corneal Limbal Stem Cell Transplant
  •  Artifical Cornea Transplant
  •  Others

On the basis of procedure type, the market is segmented into endothelial keratoplasty, penetrating keratoplasty, Anterior Lamellar Keratoplasty (ALK), corneal limbal stem cell transplant, artifical cornea transplant and others.

Type

  • Human Cornea
  • Synthetic

On the basis of type, the market is segmented into human cornea and synthetic.

Donor Type

On the basis of donor type, the market is segmented into allograft and autograft.

Graft Type

  • Partial Thickness Grafts (Lamellar)
  • Full Thickness Grafts (Penetrating)

On the basis of graft type, the market is segmented into partial thickness grafts (lamellar), full thickness grafts (penetrating).

Surgery Type

  • Conventional Surgery
  • Laser-Assisted Surgery

On the basis of surgery type, the market is segmented into conventional surgery and laser-assisted surgery.

Indication

  • Fuch's Endothelial Dystrophy
  •  Infectious Keratitis
  •  Bullous Keratopathy
  •  Keratoconus
  •  Regraft Procedures
  •  Corneal Scarring
  •  Corneal Ulcers
  •  Others

On the basis of indication, the market is segmented into fuch's endothelial dystrophy, infectious keratitis, bullous keratopathy, keratoconus, regraft procedures, corneal scarring, corneal ulcers and others.

Gender

  • Female
  • Male

On the basis of gender, the market is segmented into female and male.

Age Group

  • Geriatric
  •  Adult
  •  Pediatric

On the basis of age group, the market is segmented into geriatric, adult and pediatric.

End User

On the basis of end user, the market is segmented into hospitals, eye clinics, ambulatory surgical centers, academic & research institutes and others.

North America Corneal Transplant Market Regional Analysis/Insights

North America corneal transplant market is analyzed, and market size insights and trends are provided based on procedure type, type, donor type, graft type, surgery type, indication, gender, age group, and end user as referenced above.

The countries covered in this market report are U.S., Canada, and Mexico.

North America is expected to dominate the market due to factors like high prevalence of infections, advanced healthcare infrastructure, strong consumer awareness and purchasing power, ongoing research and development initiatives, established marketing and distribution networks

The U.S. is expected to dominate in the North America market due to factors such as large population, high healthcare expenditure, sophisticated healthcare system, extensive pharmaceutical industry, and widespread consumer awareness.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and North America Corneal Transplant Market Share Analysis

The North America corneal transplant market is segmented into eight notable segments based on procedure type, donor type, graft type, surgery type, indication, gender, age group, and end user.

The North America corneal transplant market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, regional presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on the North America corneal transplant market.

Some of the major players operating in the the North America corneal transplant market are ZEISS Group (Carl Zeiss Meditec AG.), Alcon, CorneaGen, Ziemer Ophthalmic Systems AG, RUMEX International Co., among others.


SKU-

Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo

  • Panel de análisis de datos interactivo
  • Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
  • Acceso de analista de investigación para personalización y consultas
  • Análisis de la competencia con panel interactivo
  • Últimas noticias, actualizaciones y análisis de tendencias
  • Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Solicitud de demostración

Tabla de contenido

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE NORTH AMERICA CORNEAL IMPLANTS MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET END USER COVERAGE GRID

2.8 DBMR MARKET POSITION GRID

2.9 VENDOR SHARE ANALYSIS

2.1 SECONDARY SOURCES

2.11 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTLE ANALYSIS

4.2 PORTERS FIVE FORCES ANALYSIS

5 NORTH AMERICA CORNEAL TRANSPLANT MARKET: REGULATIONS

5.1 REGULATORY AUTHORITIES IN THE ASIA-PACIFIC REGION

5.2 NORTH AMERICA REGULATORY SCENARIO

5.3 EUROPE REGULATORY SCENARIO

5.4 MIDDLE EAST AND AFRICA REGULATORY SCENARIO

5.5 SOUTH AMERICA REGULATORY SCENARIO

6 CUSTOMIZATION

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 INCREASING PREVALENCE OF EYE DISEASES

7.1.2 RISING GERIATRIC POPULATION

7.1.3 TECHNOLOGICAL ADVANCEMENTS IN CORNEAL IMPLANTS

7.1.4 RISE IN MINIMALLY INVASIVE SURGERY IN CORNEAL TRANSPLANT

7.2 RESTRAINTS

7.2.1 HIGH COST ASSOCIATED WITH CORNEAL TRANSPLANT SURGERY

7.2.2 SHORTAGE OF DONORS IN CORNEAL TRANSPLANT

7.3 OPPORTUNITIES

7.3.1 RISE IN HEALTHCARE INFRASTRUCTURE

7.3.2 INCREASE IN PUBLIC AWARENESS AND EDUCATION

7.3.3 PARTNERSHIPS AND COLLABORATIONS ASSOCIATED WITH CORNEAL TRANSPLANTS

7.4 CHALLENGES

7.4.1 SURGICAL AND POST-SURGICAL COMPLICATIONS

7.4.2 LIMITED AWARENESS AND TRAINING

8 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY TYPE

8.1 OVERVIEW

8.2 HUMAN CORNEA

8.3 SYNTHETIC

9 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE

9.1 OVERVIEW

9.2 ENDOTHELIAL KERATOPLASTY

9.2.1 DESCEMET'S MEMBRANE ENDOTHELIAL KERATOPLASTY (DMEK)

9.2.2 DESCEMET'S STRIPPING ENDOTHELIAL KERATOPLASTY(DSEK)/DESCEMET'S STRIPPING AUTOMATED ENDOTHELIAL KERATOPLASTY (DSAEK)

9.3 PENETRATING KERATOPLASTY

9.4 ANTERIOR LAMELLAR KERATOPLASTY (ALK)

9.4.1 DEEP ANTERIOR LAMELLAR KERATOPLASTY (DALK)

9.4.2 SUPERFICIAL ANTERIOR LAMELLAR KERATOPLASTY (SALK)

9.5 CORNEAL LIMBAL STEM CELL TRANSPLANT

9.6 ARTIFICIAL CORNEA TRANSPLANT

9.7 OTHERS

10 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE

10.1 OVERVIEW

10.2 ALLOGRAFT

10.3 AUTOGRAFT

11 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY INDICATION

11.1 OVERVIEW

11.2 FUCH'S ENDOTHELIAL DYSTROPHY

11.3 INFECTIOUS KERATITIS

11.4 BULLOUS KERATOPATHY

11.5 KERATOCONUS

11.6 REGRAFT PROCEDURES

11.7 CORNEAL SCARRING

11.8 CORNEAL ULCERS

11.9 OTHERS

12 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE

12.1 OVERVIEW

12.2 PARTIAL THICKNESS GRAFTS (LAMELLAR)

12.2.1 DEEP LAMELLAR GRAFTS

12.2.2 SUPERFICIAL LAMELLAR GRAFTS

12.3 FULL THICKNESS GRAFTS (PENETRATING)

13 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE

13.1 OVERVIEW

13.2 CONVENTIONAL SURGERY

13.3 LASER-ASSISTED SURGERY

14 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY GENDER

14.1 OVERVIEW

14.2 FEMALE

14.3 MALE

15 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY AGE GROUP

15.1 OVERVIEW

15.2 GERIATRIC

15.3 ADULT

15.4 PEDIATRIC

16 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY END USER

16.1 OVERVIEW

16.2 HOSPITALS

16.3 EYE CLINICS

16.4 AMBULATORY SURGICAL CENTERS

16.5 ACADEMIC & RESEARCH INSTITUTES

16.6 OTHERS

17 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY REGION

17.1 NORTH AMERICA

17.1.1 U.S

17.1.2 CANADA

17.1.3 MEXICO

18 NORTH AMERICA CORNEAL TRANSPLANT MARKET: COMPANY LANDSCAPE

18.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

19 SWOT ANALYSIS

20 COMPANY PROFILES

20.1 ZEISS GROUP (CARL ZEISS MEDITEC AG.)

20.1.1 COMPANY SNAPSHOT

20.1.2 REVENUE ANALYSIS

20.1.3 COMPANY SHARE ANALYSIS

20.1.4 PRODUCT PORTFOLIO

20.1.5 RECENT DEVELOPMENTS

20.2 ALCON

20.2.1 COMPANY SNAPSHOT

20.2.2 REVENUE ANALYSIS

20.2.3 COMPANY SHARE ANALYSIS

20.2.4 PRODUCT PORTFOLIO

20.2.5 RECENT DEVELOPMENT

20.3 CORNEAGEN

20.3.1 COMPANY SNAPSHOT

20.3.2 COMPANY SHARE ANALYSIS

20.3.3 PRODUCT PORTFOLIO

20.3.4 RECENT DEVELOPMENT

20.4 ZIEMER OPHTHALMIC SYSTEMS AG

20.4.1 COMPANY SNAPSHOT

20.4.2 COMPANY SHARE ANALYSIS

20.4.3 PRODUCT PORTFOLIO

20.4.4 RECENT DEVELOPMENT

20.5 RUMEX INTERNATIONAL CO.

20.5.1 COMPANY SNAPSHOT

20.5.2 COMPANY SHARE ANALYSIS

20.5.3 PRODUCT PORTFOLIO

20.5.4 RECENT DEVELOPMENT

20.6 AJL OPHTHALMIC S.A.

20.6.1 COMPANY SNAPSHOT

20.6.2 PRODUCT PORTFOLIO

20.6.3 RECENT DEVELOPMENT

20.7 CORNEAT VISION

20.7.1 COMPANY SNAPSHOT

20.7.2 PRODUCT PORTFOLIO

20.7.3 RECENT DEVELOPMENT

20.8 FLORIDA LIONS EYE BANK

20.8.1 COMPANY SNAPSHOT

20.8.2 PRODUCT PORTFOLIO

20.8.3 RECENT DEVELOPMENT

20.9 KERAMED, INC.

20.9.1 COMPANY SNAPSHOT

20.9.2 PRODUCT PORTFOLIO

20.9.3 RECENT DEVELOPMENT

20.1 MASSACHUSETTS EYE AND EAR

20.10.1 COMPANY SNAPSHOT

20.10.2 PRODUCT PORTFOLIO

20.10.3 RECENT DEVELOPMENT

20.11 OCL VISION

20.11.1 COMPANY SNAPSHOT

20.11.2 SERVICE PORTFOLIO

20.11.3 RECENT DEVELOPMENT

20.12 OVATION INTERNATIONAL

20.12.1 COMPANY SNAPSHOT

20.12.2 PRODUCT PORTFOLIO

20.12.3 RECENT DEVELOPMENT

20.13 SAN DIEGO EYE BANK

20.13.1 COMPANY SNAPSHOT

20.13.2 SERVICE PORTFOLIO

20.13.3 RECENT DEVELOPMENT

21 QUESTIONNAIRE

22 RELATED REPORTS

Lista de Tablas

TABLE 1 NUMBER OF CORNEAL TRANSPLANTS IN EACH COUNTRY, BY SURGERY TYPE

TABLE 2 NUMBER OF CORNEAL TRANSPLANTS IN EACH COUNTRY, BY INDICATION

TABLE 3 NUMBER OF CORNEAL TRANSPLANTS IN EACH COUNTRY, BY AGE

TABLE 4 NUMBER OF PATIENTS WAITING IN EACH COUNTRY

TABLE 5 NUMBER OF CORNEAL TRANSPLANTS IN EACH COUNTRY, BY DONOR TYPE

TABLE 6 PERCENTAGE OF HOSPITALS IN EACH COUNTRY WHERE CORNEAL TRANSPLANTS ARE PERFORMED (CLINICS OR HOSPITALS).

TABLE 7 AVERAGE COST FOR THE CORNEAL TRANSPLANT (PER/EYE) WITH RESPECT TO THE PROCEDURE TYPE IN ASIA-PACIFIC (INDIA)

TABLE 8 AVERAGE COST FOR THE CORNEAL TRANSPLANT WITH RESPECT TO THE PROCEDURE TYPE IN EUROPE

TABLE 9 AVERAGE COST FOR THE CORNEAL TRANSPLANT WITH RESPECT TO THE PROCEDURE TYPE IN SOUTH AMERICA

TABLE 10 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 11 NORTH AMERICA HUMAN CORNEA IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 12 NORTH AMERICA SYNTHETIC IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 13 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)

TABLE 14 NORTH AMERICA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 15 NORTH AMERICA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 16 NORTH AMERICA PENETRATING KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 17 NORTH AMERICA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 18 NORTH AMERICA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 19 NORTH AMERICA CORNEAL LIMBAL STEM CELL TRANSPLANT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 20 NORTH AMERICA ARTIFICIAL CORNEA TRANSPLANT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 21 NORTH AMERICA OTHERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 22 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)

TABLE 23 NORTH AMERICA ALLOGRAFT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 24 NORTH AMERICA ALLOGRAFT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 25 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)

TABLE 26 NORTH AMERICA FUCH'S ENDOTHELIAL DYSTROPHY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 27 NORTH AMERICA INFECTIOUS KERATITIS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 28 NORTH AMERICA BULLOUS KERATOPATHY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 29 NORTH AMERICA KERATOCONUS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 30 NORTH AMERICA REGRAFT PROCEDURES IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 31 NORTH AMERICA CORNEAL SCARRING IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 32 NORTH AMERICA CORNEAL ULCERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 33 NORTH AMERICA OTHERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 34 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)

TABLE 35 NORTH AMERICA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 36 NORTH AMERICA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)

TABLE 37 NORTH AMERICA FULL THICKNESS GRAFTS (PENETRATING) IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 38 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)

TABLE 39 NORTH AMERICA CONVENTIONAL SURGERY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 40 NORTH AMERICA LASER-ASSISTED SURGERY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 41 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 42 NORTH AMERICA FEMALE IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 43 NORTH AMERICA MALE IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 44 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)

TABLE 45 NORTH AMERICA GERIATRIC IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 46 NORTH AMERICA ADULT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 47 NORTH AMERICA PEDIATRIC IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 48 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 49 NORTH AMERICA HOSPITALS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 50 NORTH AMERICA EYE CLINICS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 51 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 52 NORTH AMERICA ACADEMIC & RESEARCH INSTITUTES IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 53 NORTH AMERICA OTHERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 54 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 55 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)

TABLE 56 NORTH AMERICA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 57 NORTH AMERICA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 58 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 59 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)

TABLE 60 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)

TABLE 61 NORTH AMERICA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)

TABLE 62 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)

TABLE 63 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)

TABLE 64 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 65 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)

TABLE 66 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 67 U.S. CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)

TABLE 68 U.S. ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 69 U.S. ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 70 U.S. CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 71 U.S. CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)

TABLE 72 U.S. CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)

TABLE 73 U.S. PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)

TABLE 74 U.S. CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)

TABLE 75 U.S. CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)

TABLE 76 U.S. CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 77 U.S. CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)

TABLE 78 U.S. CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 79 CANADA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)

TABLE 80 CANADA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 81 CANADA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 82 CANADA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 83 CANADA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)

TABLE 84 CANADA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)

TABLE 85 CANADA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)

TABLE 86 CANADA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)

TABLE 87 CANADA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)

TABLE 88 CANADA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 89 CANADA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)

TABLE 90 CANADA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 91 MEXICO CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)

TABLE 92 MEXICO ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 93 MEXICO ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 94 MEXICO CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 95 MEXICO CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)

TABLE 96 MEXICO CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)

TABLE 97 MEXICO PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)

TABLE 98 MEXICO CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)

TABLE 99 MEXICO CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)

TABLE 100 MEXICO CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 101 MEXICO CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)

TABLE 102 MEXICO CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)

Lista de figuras

FIGURE 1 NORTH AMERICA CORNEAL TRANSPLANT MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA CORNEAL TRANSPLANT MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA CORNEAL TRANSPLANT MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA CORNEAL TRANSPLANT MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA CORNEAL TRANSPLANT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA CORNEAL TRANSPLANT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA CORNEAL TRANSPLANT MARKET: MARKET END USER COVERAGE GRID

FIGURE 8 NORTH AMERICA CORNEAL TRANSPLANT MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA CORNEAL TRANSPLANT MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 NORTH AMERICA CORNEAL TRANSPLANT MARKET: SEGMENTATION

FIGURE 11 SIX SEGMENTS COMPRISE THE NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE

FIGURE 12 EXECUTIVE SUMMARY

FIGURE 13 STRATEGIC DECISIONS

FIGURE 14 INCREASING PREVALENCE OF EYE DISEASES IS DRIVING THE GROWTH OF THE NORTH AMERICA CORNEAL TRANSPLANT MARKET FROM 2024 TO 2031

FIGURE 15 THE ENDOTHELIAL KERATOPLASTY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA CORNEAL TRANSPLANT MARKET IN 2024 AND 2031

FIGURE 16 DROC ANALYSIS

FIGURE 17 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY TYPE, 2023

FIGURE 18 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY TYPE, 2024-2031 (USD THOUSAND)

FIGURE 19 NORTH AMERICA CORNEAL TRANSPLANT MARKET: TYPE, CAGR (2024-2031)

FIGURE 20 NORTH AMERICA CORNEAL TRANSPLANT MARKET: TYPE, LIFELINE CURVE

FIGURE 21 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY PROCEDURE TYPE, 2023

FIGURE 22 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY PROCEDURE TYPE, 2024-2031 (USD THOUSAND)

FIGURE 23 NORTH AMERICA CORNEAL TRANSPLANT MARKET: PROCEDURE TYPE, CAGR (2024-2031)

FIGURE 24 NORTH AMERICA CORNEAL TRANSPLANT MARKET: PROCEDURE TYPE, LIFELINE CURVE

FIGURE 25 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY DONOR TYPE, 2023

FIGURE 26 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY DONOR TYPE, 2024-2031 (USD THOUSAND)

FIGURE 27 NORTH AMERICA CORNEAL TRANSPLANT MARKET: DONOR TYPE, CAGR (2024-2031)

FIGURE 28 NORTH AMERICA CORNEAL TRANSPLANT MARKET: DONOR TYPE, LIFELINE CURVE

FIGURE 29 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY INDICATION, 2023

FIGURE 30 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY INDICATION, 2024-2031 (USD THOUSAND)

FIGURE 31 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY INDICATION, CAGR (2024-2031)

FIGURE 32 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY INDICATION, LIFELINE CURVE

FIGURE 33 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY GRAFT TYPE, 2023

FIGURE 34 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY GRAFT TYPE, 2024-2031 (USD THOUSAND)

FIGURE 35 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY GRAFT TYPE, CAGR (2024-2031)

FIGURE 36 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY GRAFT TYPE, LIFELINE CURVE

FIGURE 37 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY SURGERY TYPE, 2023

FIGURE 38 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY SURGERY TYPE, 2024-2031 (USD THOUSAND)

FIGURE 39 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY SURGERY TYPE, CAGR (2024-2031)

FIGURE 40 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY SURGERY TYPE, LIFELINE CURVE

FIGURE 41 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY GENDER, 2023

FIGURE 42 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY GENDER, 2024-2031 (USD THOUSAND)

FIGURE 43 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY GENDER, CAGR (2024-2031)

FIGURE 44 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY GENDER, LIFELINE CURVE

FIGURE 45 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY AGE GROUP, 2023

FIGURE 46 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY AGE GROUP, 2024-2031 (USD THOUSAND)

FIGURE 47 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY AGE GROUP, CAGR (2024-2031)

FIGURE 48 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY AGE GROUP, LIFELINE CURVE

FIGURE 49 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY END USER, 2023

FIGURE 50 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY END USER, 2024-2031 (USD THOUSAND)

FIGURE 51 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY END USER, CAGR (2024-2031)

FIGURE 52 NORTH AMERICA CORNEAL TRANSPLANT MARKET: BY END USER, LIFELINE CURVE

FIGURE 53 NORTH AMERICA CORNEAL TRANSPLANT MARKET: SNAPSHOT (2023)

FIGURE 54 NORTH AMERICA CORNEAL TRANSPLANT MARKET: COMPANY SHARE 2023 (%)

Ver información detallada Right Arrow

Metodología de investigación

La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.

La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.

Personalización disponible

Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados ​​en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.

Preguntas frecuentes

The market is segmented based on , By Procedure Type (Endothelial Keratoplasty, Penetrating Keratoplasty, Anterior Lamellar Keratoplasty (ALK), Corneal Limbal Stem Cell Transplant, Artifical Cornea Transplant, and Others), Type (Human Cornea and Synthetic), Donor Type (Autograft and Allograft), Graft Type (Partial Thickness Grafts (Lamellar) and Full Thickness Grafts (Penetrating)), Surgery Type (Conventional Surgery, Laser-Assisted Surgery), Indication (Fuch's Endothelial Dystrophy, Infectious Keratitis, Bullous Keratopathy, Keratoconus, Regraft Procedures, Corneal Scarring, Corneal Ulcers, and Others), Gender (Female and Male), Age Group (Geriatric, Adult, and Pediatric), End User (Hospitals, Eye Clinics, Ambulatory Surgical Centers, Academic & Research Institutes, and Others) - Industry Trends and Forecast to 2031 .
The North America Corneal Transplant Market size was valued at USD 207.02 USD Million in 2023.
The North America Corneal Transplant Market is projected to grow at a CAGR of 6.2% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada, Mexico.